Участь МАРК в опосередкуваннi дiї протипухлинного препарату таксолу на клiтини анапластичного раку щитовидної залози
The role of MAPK (mitogen-activated protein kinase) in mediating the action of antitumour drug taxol on the cell line of thyroid anaplastic cancer, ARO, is studied. It is shown that taxol enhances the phosphorylation of anti-apoptotic protein Bcl-2 and activated the main executioner caspase-3. Tax...
Збережено в:
| Дата: | 2008 |
|---|---|
| Автори: | , , , |
| Формат: | Стаття |
| Мова: | Ukrainian |
| Опубліковано: |
Видавничий дім "Академперіодика" НАН України
2008
|
| Теми: | |
| Онлайн доступ: | https://nasplib.isofts.kiev.ua/handle/123456789/3925 |
| Теги: |
Додати тег
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|
| Назва журналу: | Digital Library of Periodicals of National Academy of Sciences of Ukraine |
| Цитувати: | Участь МАРК в опосередкуваннi дiї протипухлинного препарату таксолу на клiтини анапластичного раку щитовидної залози / I.Д. Попадюк, В.М. Пушкарьов, Н.М. Костюченко, М.Д. Тронько // Доп. НАН України. — 2008. — № 2. — С. 174-177. — Бібліогр.: 12 назв. — укp. |
Репозитарії
Digital Library of Periodicals of National Academy of Sciences of Ukraine| Резюме: | The role of MAPK (mitogen-activated protein kinase) in mediating the action of antitumour
drug taxol on the cell line of thyroid anaplastic cancer, ARO, is studied. It is shown that taxol enhances the phosphorylation of anti-apoptotic protein Bcl-2 and activated the main executioner
caspase-3. Taxol did not activate р38 МАРК but significantly inhibits the activation of ERK1/2, another MAP kinase that participates in survival mechanisms. The possible factor under control of this kinase can be a protein-inhibitor of apoptosis, XIAP. This suggestion is confirmed by experiments with the inhibitor of c-Raf-1/MEK1/ERK cascade, PD98059. In the presence of the inhibitor, the XIAP quantity essentially decreased as well as the cell viability. The possible
means of augmentation of the taxol cancerostatic effect upon thyroid cancer cells are discussed. |
|---|